The kinetics of antibody binding to Plasmodium falciparum VAR2CSA PfEMP1 antigen and modelling of PfEMP1 antigen packing on the membrane knobs.
BACKGROUND
Infected humans make protective antibody responses to the PfEMP1 adhesion antigens exported by Plasmodium falciparum parasites to the erythrocyte membrane, but little is known about the kinetics of this antibody-receptor binding reaction or how the topology of PfEMP1 on the parasitized erythrocyte membrane influences antibody association with, and dissociation from, its antigenic target.


METHODS
A Quartz Crystal Microbalance biosensor was used to measure the association and dissociation kinetics of VAR2CSA PfEMP1 binding to human monoclonal antibodies. Immuno-fluorescence microscopy was used to visualize antibody-mediated adhesion between the surfaces of live infected erythrocytes and atomic force microscopy was used to obtain higher resolution images of the membrane knobs on the infected erythrocyte to estimate knob surface areas and model VAR2CSA packing density on the knob.


RESULTS
Kinetic analysis indicates that antibody dissociation from the VAR2CSA PfEMP1 antigen is extremely slow when there is a high avidity interaction. High avidity binding to PfEMP1 antigens on the surface of P. falciparum-infected erythrocytes in turn requires bivalent cross-linking of epitopes positioned within the distance that can be bridged by antibody. Calculations of the surface area of the knobs and the possible densities of PfEMP1 packing on the knobs indicate that high-avidity cross-linking antibody reactions are constrained by the architecture of the knobs and the large size of PfEMP1 molecules.


CONCLUSIONS
High avidity is required to achieve the strongest binding to VAR2CSA PfEMP1, but the structures that display PfEMP1 also tend to inhibit cross-linking between PfEMP1 antigens, by holding many binding epitopes at distances beyond the 15-18 nm sweep radius of an antibody. The large size of PfEMP1 will also constrain intra-knob cross-linking interactions. This analysis indicates that effective vaccines targeting the parasite's vulnerable adhesion receptors should primarily induce strongly adhering, high avidity antibodies whose association rate constant is less important than their dissociation rate constant.
Joergensen
Lars M
LM
Centre for Medical Parasitology, Department of International Health, Immunology & Microbiology, Faculty of Health Sciences, University of Copenhagen and Department of Infectious Diseases, Copenhagen University Hospital (Rigshospitalet), CSS Øster Farimagsgade 5, Building 22 & 23, Postbox 2099, 1014 Copenhagen K, Denmark. lars.m.jorgensen@gmail.com
Salanti
Ali
A
Dobrilovic
Tina
T
Barfod
Lea
L
Hassenkam
Tue
T
Theander
Thor G
TG
Hviid
Lars
L
Arnot
David E
DE
D000913:Antibodies, Protozoan / Q000276:immunology; D000953:Antigens, Protozoan / Q000276:immunology* / Q000378:metabolism; D001665:Binding Sites; D004910:Erythrocyte Membrane / Q000276:immunology / Q000469:parasitology / Q000648:ultrastructure; D006801:Humans; D007074:Immunoglobulin G / Q000276:immunology; D007700:Kinetics; D018625:Microscopy, Atomic Force; D018613:Microscopy, Confocal / Q000379:methods; D008856:Microscopy, Fluorescence; D010963:Plasmodium falciparum / Q000276:immunology*; D011485:Protein Binding; D015800:Protozoan Proteins / Q000276:immunology* / Q000378:metabolism
D000913:Antibodies, Protozoan; D000953:Antigens, Protozoan; D007074:Immunoglobulin G; D015800:Protozoan Proteins; C512601:VAR2CSA protein, Plasmodium falciparum; C085731:erythrocyte membrane protein 1, Plasmodium falciparum
Blood. 2006 Jul 1;108(1):370-8
16507777
Exp Parasitol. 1996 Dec;84(3):339-43
8948323
Parasitology. 1999 Jul;119 ( Pt 1):7-17
10446700
J Immunol. 2000 Sep 15;165(6):3309-16
10975848
Infect Immun. 2006 May;74(5):3035-8
16622246
Cell. 1995 Jul 14;82(1):77-87
7541722
FEBS Lett. 1998 Jul 31;432(1-2):45-9
9710248
Biochem J. 1959 Sep;73:119-26
14434282
J Immunol Methods. 1999 Dec 10;231(1-2):177-89
10648937
Eur J Cell Biol. 1988 Feb;45(2):192-9
2966734
J Immunol. 1992 Sep 15;149(6):2047-54
1517569
Parasitol Res. 2002 Jan;88(1):16-20
11822732
Infect Immun. 2006 Jul;74(7):4357-60
16790811
J Mol Biol. 2002 May 24;319(1):9-18
12051932
Exp Parasitol. 1977 Jun;42(1):157-64
405234
Mol Biochem Parasitol. 2000 May;108(2):237-47
10838226
J Infect Dis. 1999 Aug;180(2):464-72
10395863
Blood. 2009 Jun 11;113(24):6237-45
19369229
J Protozool. 1985 Aug;32(3):424-9
2931514
J Exp Med. 1979 Nov 1;150(5):1241-54
91658
Biophys Chem. 2002 Sep 3;99(1):31-41
12223237
Adv Parasitol. 1990;29:151-214
2181827
J Immunol. 2008 Aug 1;181(3):1988-2000
18641336
Nat Protoc. 2008;3(12):1990-6
19180081
Malar J. 2008 Aug 16;7:155
18706102
Bull World Health Organ. 1966;35(6):883-5
5338378
Nat Med. 1998 Mar;4(3):358-60
9500614
J Struct Biol. 2000 May;130(1):34-44
10806089
Mol Microbiol. 2003 Jul;49(1):179-91
12823820
J Infect Dis. 2003 Feb 15;187(4):667-74
12599084
J Cell Sci. 1986 Mar;81:1-16
3525580
Science. 2000 Aug 4;289(5480):739-45
10926528
Biochim Biophys Acta. 2000 Nov 15;1502(3):461-70
11068188
Curr Opin Microbiol. 2003 Aug;6(4):371-6
12941407
Mol Microbiol. 2007 Jan;63(2):335-47
17176260
Infect Immun. 2007 May;75(5):2415-20
17283085
Ann Trop Med Parasitol. 1997 Oct;91(7):689-92
9625922
Infect Immun. 2007 Jan;75(1):211-9
17074852
Infect Immun. 2003 Aug;71(8):4767-71
12874359
J Exp Med. 2004 May 3;199(9):1179-90
15123742
Mol Biochem Parasitol. 2006 Apr;146(2):192-7
16442168
J Biol Chem. 2008 Aug 8;283(32):21842-6
18550531
Science. 1986 Jan 10;231(4734):150-3
2417315
Acta Crystallogr Sect F Struct Biol Cryst Commun. 2008 Mar 1;64(Pt 3):221-3
18323614
PLoS One. 2007 Sep 19;2(9):e910
17878945
Trends Parasitol. 2004 Feb;20(2):66-72
14747019
PLoS Pathog. 2008 Feb 8;4(2):e42
18282103
J Microbiol Methods. 2006 Sep;66(3):434-9
16519955
Infect Immun. 2006 May;74(5):2867-75
16622225
Malar J. 2008 Jun 05;7:101
18533996
Parasite Immunol. 2004 Nov-Dec;26(11-12):477-86
15771683
Science. 2001 Sep 14;293(5537):2098-100
11557894
Infect Immun. 1999 Feb;67(2):733-9
9916084
J Cell Biol. 1983 Sep;97(3):795-802
6350320
Mol Pharmacol. 2009 Jan;75(1):1-12
18945819
Nature. 1961 Nov 25;192:733-7
13880318
Mol Biochem Parasitol. 2002 Jan;119(1):125-9
11755194
J Electron Microsc (Tokyo). 2000;49(3):429-35
11108031
J Immunol. 2007 Jan 1;178(1):428-35
17182581
Infect Immun. 2005 Sep;73(9):5903-7
16113309
Immunol Lett. 2000 Feb 1;71(2):117-26
10714439
J Cell Sci. 2005 Jun 1;118(Pt 11):2507-18
15923663
Anal Biochem. 1998 Aug 1;261(2):149-58
9716417
Infect Immun. 2007 Dec;75(12):5967-73
17923524
J Virol. 2005 Oct;79(19):12311-20
16160158
J Exp Med. 2004 Nov 1;200(9):1197-203
15520249
Int J Parasitol. 2009 May;39(6):655-64
19162031
Infect Immun. 2001 Jun;69(6):3713-8
11349035
J Struct Biol. 2005 May;150(2):163-9
15866739
Parasite Immunol. 2003 Aug-Sep;25(8-9):421-7
14651589
Exp Parasitol. 1992 Nov;75(3):281-92
1426131